203 related articles for article (PubMed ID: 15356041)
1. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.
Brownstein CM; Mertens AC; Mitby PA; Stovall M; Qin J; Heller G; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4422-7. PubMed ID: 15356041
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
Lerner SE; Huang GJ; McMahon D; Sklar CA; Oberfield SE
J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765
[TBL] [Abstract][Full Text] [Related]
3. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
4. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
[TBL] [Abstract][Full Text] [Related]
5. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
7. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
[TBL] [Abstract][Full Text] [Related]
8. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
9. [Growth hormone treatment in childhood cancer survivors].
Sampaio M; Oliveira A; Soro I; Costa C; Castro-Correia C; Fontoura M
Acta Med Port; 2011 Dec; 24 Suppl 2():393-8. PubMed ID: 22849927
[TBL] [Abstract][Full Text] [Related]
10. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
Beckers D; Thomas M; Jamart J; Francois I; Maes M; Lebrethon MC; De Waele K; Tenoutasse S; De Schepper J
Eur J Endocrinol; 2010 Mar; 162(3):483-90. PubMed ID: 19969557
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
Quintos JB; Vogiatzi MG; Harbison MD; New MI
J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
[TBL] [Abstract][Full Text] [Related]
12. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
de Ridder MA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
[TBL] [Abstract][Full Text] [Related]
14. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
15. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency.
Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J
Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010
[TBL] [Abstract][Full Text] [Related]
16. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
Lin-Su K; Vogiatzi MG; Marshall I; Harbison MD; Macapagal MC; Betensky B; Tansil S; New MI
J Clin Endocrinol Metab; 2005 Jun; 90(6):3318-25. PubMed ID: 15797962
[TBL] [Abstract][Full Text] [Related]
17. Prediction of adult height in growth-hormone-treated children with growth hormone deficiency.
de Ridder MA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Mar; 92(3):925-31. PubMed ID: 17179199
[TBL] [Abstract][Full Text] [Related]
18. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
Geffner M; Lundberg M; Koltowska-Häggström M; Abs R; Verhelst J; Erfurth EM; Kendall-Taylor P; Price DA; Jonsson P; Bakker B
J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
[TBL] [Abstract][Full Text] [Related]
19. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation.
Vandecruys E; Dhooge C; Craen M; Benoit Y; De Schepper J
J Pediatr; 2013 Jul; 163(1):268-73. PubMed ID: 23351599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
